Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection

被引：0
|
作者：
Xiao-Hui Wang
Zi-Li Hu
Yi-Zhen Fu
Jing-Yu Hou
Wen-Xuan Li
Yao-Jun Zhang
Li Xu
Qun-Fang Zhou
Min-Shan Chen
Zhong-Guo Zhou
机构：
[1] Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University,Department of Hepatobiliary Surgery
[2] Sun Yat-Sen University Cancer Center,Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China
[3] Sun Yat-Sen University Cancer Center,Department of Liver Surgery
[4] The Second Affiliated Hospital of Guangzhou Medical University,Department of Minimally Invasive Interventional Radiology, and Department of Radiology
来源：
Journal of Gastroenterology | 2022年 / 57卷
关键词：
Tenofovir; Entecavir; Hepatocellular carcinoma; Curative resection; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：185 / 198
页数：13
相关论文
共 50 条
  • [21] Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma
    Kubo, S
    Hirohashi, K
    Tanaka, H
    Tsukamoto, T
    Shuto, T
    Higaki, I
    Takemura, S
    Yamamoto, T
    Nishiguchi, S
    Kinoshita, H
    DIGESTIVE SURGERY, 2001, 18 (01) : 26 - 33
  • [22] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Lee, Hye Won
    Cho, Young Youn
    Lee, Hyein
    Lee, Jae Seung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    Park, Soo Young
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1083 - 1092
  • [23] Development and validation of prognostic dynamic nomograms for hepatitis B Virus-related hepatocellular carcinoma with microvascular invasion after curative resection
    Bai, Shilei
    Yang, Pinghua
    Wei, Yanping
    Wang, Jie
    Lu, Caixia
    Xia, Yong
    Si, Anfeng
    Zhang, Baohua
    Shen, Feng
    Tan, Yexiong
    Wang, Kui
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Hye Won Lee
    Young Youn Cho
    Hyein Lee
    Jae Seung Lee
    Seung Up Kim
    Jun Yong Park
    Do Young Kim
    Sang Hoon Ahn
    Beom Kyung Kim
    Soo Young Park
    Hepatology International, 2021, 15 : 1083 - 1092
  • [25] Antiviral therapy after curative treatment of hepatocellular carcinoma in patients with chronic hepatitis B infection: Is tenofovir or entecavir preferred?
    van Erpecum, Karel J.
    Sonneveld, Milan J.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 89 : 27 - 29
  • [26] Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma
    Liang, Yuxin
    Zhong, Deyuan
    Zhang, Zilong
    Su, Yuhao
    Yan, Su
    Lai, Chunyou
    Yao, Yutong
    Shi, Ying
    Huang, Xiaolun
    Shang, Jin
    BMC CANCER, 2024, 24 (01)
  • [27] Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection
    Yoo, Sun
    Kim, Ji Yoon
    Lim, Young-Suk
    Han, Seungbong
    Choi, Jonggi
    JOURNAL OF HEPATOLOGY, 2022, 77 (04) : 939 - 946
  • [28] Significance of viral status on prognosis of hepatitis B-related hepatocellular carcinoma after curative resection in East Asia
    Qu, Li-Shuai
    Zhang, Hai-Feng
    HEPATOLOGY RESEARCH, 2016, 46 (01) : 40 - 49
  • [29] Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis
    Goyal S.K.
    Dixit V.K.
    Shukla S.K.
    Ghosh J.
    Behera M.
    Tripathi M.
    Gupta N.
    Ranjan A.
    Jain A.K.
    Indian Journal of Gastroenterology, 2015, 34 (4) : 286 - 291
  • [30] Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma
    Zhang, Yuan-Qing
    Guo, Jin-Sheng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 3860 - 3866
12345